Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma, Follicular × selpercatinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Medullary 3 Thyroid Neoplasms 2 Sarcoma 2 Wilms Tumor 1 Thyroid Diseases 1 Thyroid Cancer, Papillary 1 Thoracic Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms by Site 1 Neoplasms 1 Myofibromatosis 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lung Neoplasms 1 Lung Diseases 1 Histiocytosis, Langerhans-Cell 1 Hepatoblastoma 1 Head and Neck Neoplasms 1 Glioma 1 Ependymoma 1 Endocrine System Diseases 1

Interventions

lenvatinib 3 Sunitinib 3 cabozantinib 2 vandetanib 1 tremelimumab 1 tanespimycin 1 pembrolizumab 1 durvalumab 1 cediranib 1 Vorinostat 1 Sorafenib 1 Pharmacogenomic Testing 1 Lenalidomide 1 Iodine-131 1 Gefitinib 1 Bortezomib 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡